SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Galirayo who wrote (20803)12/12/2006 8:30:15 PM
From: ACAN  Read Replies (1) of 23958
 
Ray; [GNBT]

Another hedge fund is being taken to task for alleged naked short-selling and insider trading in dozens of unregistered securities.

Gryphon Partners, the $310 million Dallas hedge fund run by Edwin "Bucky" Lyon, is the target of a federal civil lawsuit filed Tuesday by the Securities and Exchange Commission, alleging securities fraud in trading of shares in 35 unregistered securities offerings.

The companies caught up in the alleged scheme are hardly household names: Medis Technologies (nasdaq: MDTL - news - people ), Generex Biotechnology (nasdaq: GNBT - news - people ), Immune Response and PhotoMedex (nasdaq: PHMD - news - people ), to name a few. But that is generally the pattern of many cases involving allegations of manipulative trading.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext